Copernicus Therapeutics
Cleveland · Founded 1995
About Copernicus Therapeutics
Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company and a leader in the emerging field of precision medicine and gene therapy. Through their proprietary, non-viral, nucleic acid nanoparticle platform, they are able to achieve robust gene transfer in several tissues without the immune response and limited treatment window of AAV.
Company Facts
- Founded: 1995
- Legal name: Copernicus Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.6M
- Last round: Grant (Jun 2008)
- Website: cgsys.com
- Phone: +1 (216) 534-6164
Social Profiles
Canonical: https://fsome.com/organization/copernicus-therapeutics-8270608 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.